Global and Region Personal Genome Testing Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Personal Genome Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Personal Genome Testingmarket, defines the market attractiveness level of Personal Genome Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Personal Genome Testing industry, describes the types of Personal Genome Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Personal Genome Testing market and the development prospects and opportunities of Personal Genome Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Personal Genome Testing market in Chapter 13.

    By Player:

    • PierianDx

    • Perkin Elmer, Inc

    • F Hoffman-La Roche Ltd

    • Oxford Nanopore Technologies

    • DNASTAR, Inc

    • Genomatix GmbH

    • Bio-Rad Laboratories, Inc

    • BGI

    • Thermo Fisher Scientific, Inc

    • Illumina

    • Eurofins GATC Biotech GmbH

    • QIAGEN

    By Type:

    • Targeted Testing

    • Non-Targeted Testing

    • Multi-Targeted Testing

    By End-User:

    • Neurological Disorders

    • Oncology

    • Metabolic Disorders

    • Autoimmune Disorders

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Personal Genome Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Personal Genome Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Personal Genome Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Personal Genome Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Personal Genome Testing Market Analysis and Outlook to 2022

    • 7.1 Global Personal Genome Testing Consumption (2017-2022)

    • 7.2 United States Personal Genome Testing Consumption (2017-2022)

    • 7.3 Europe Personal Genome Testing Consumption (2017-2022)

    • 7.4 China Personal Genome Testing Consumption (2017-2022)

    • 7.5 Japan Personal Genome Testing Consumption (2017-2022)

    • 7.6 India Personal Genome Testing Consumption (2017-2022)

    • 7.7 South Korea Personal Genome Testing Consumption (2017-2022)

    8 Region and Country-wise Personal Genome Testing Market Analysis and Outlook to 2028

    • 8.1 Global Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.2 United States Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.4 China Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.6 India Personal Genome Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Personal Genome Testing Consumption Forecast (2022-2028)

    9 Global Personal Genome Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Personal Genome Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Targeted Testing Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-Targeted Testing Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Multi-Targeted Testing Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personal Genome Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Personal Genome Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Personal Genome Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Multi-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Personal Genome Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Personal Genome Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Personal Genome Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Personal Genome Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Personal Genome Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Personal Genome Testing Market Competitive Analysis

    • 14.1 PierianDx

      • 14.1.1 PierianDx Company Details

      • 14.1.2 PierianDx Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 PierianDx Personal Genome Testing Product and Service

    • 14.2 Perkin Elmer, Inc

      • 14.2.1 Perkin Elmer, Inc Company Details

      • 14.2.2 Perkin Elmer, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Perkin Elmer, Inc Personal Genome Testing Product and Service

    • 14.3 F Hoffman-La Roche Ltd

      • 14.3.1 F Hoffman-La Roche Ltd Company Details

      • 14.3.2 F Hoffman-La Roche Ltd Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 F Hoffman-La Roche Ltd Personal Genome Testing Product and Service

    • 14.4 Oxford Nanopore Technologies

      • 14.4.1 Oxford Nanopore Technologies Company Details

      • 14.4.2 Oxford Nanopore Technologies Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Oxford Nanopore Technologies Personal Genome Testing Product and Service

    • 14.5 DNASTAR, Inc

      • 14.5.1 DNASTAR, Inc Company Details

      • 14.5.2 DNASTAR, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 DNASTAR, Inc Personal Genome Testing Product and Service

    • 14.6 Genomatix GmbH

      • 14.6.1 Genomatix GmbH Company Details

      • 14.6.2 Genomatix GmbH Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genomatix GmbH Personal Genome Testing Product and Service

    • 14.7 Bio-Rad Laboratories, Inc

      • 14.7.1 Bio-Rad Laboratories, Inc Company Details

      • 14.7.2 Bio-Rad Laboratories, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bio-Rad Laboratories, Inc Personal Genome Testing Product and Service

    • 14.8 BGI

      • 14.8.1 BGI Company Details

      • 14.8.2 BGI Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 BGI Personal Genome Testing Product and Service

    • 14.9 Thermo Fisher Scientific, Inc

      • 14.9.1 Thermo Fisher Scientific, Inc Company Details

      • 14.9.2 Thermo Fisher Scientific, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Thermo Fisher Scientific, Inc Personal Genome Testing Product and Service

    • 14.10 Illumina

      • 14.10.1 Illumina Company Details

      • 14.10.2 Illumina Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Illumina Personal Genome Testing Product and Service

    • 14.11 Eurofins GATC Biotech GmbH

      • 14.11.1 Eurofins GATC Biotech GmbH Company Details

      • 14.11.2 Eurofins GATC Biotech GmbH Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Eurofins GATC Biotech GmbH Personal Genome Testing Product and Service

    • 14.12 QIAGEN

      • 14.12.1 QIAGEN Company Details

      • 14.12.2 QIAGEN Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 QIAGEN Personal Genome Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Personal Genome Testing

    • Figure Personal Genome Testing Picture

    • Table Global Personal Genome Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personal Genome Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personal Genome Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Personal Genome Testing Consumption by Country (2017-2022)

    • Figure United States Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure China Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure India Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personal Genome Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Personal Genome Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personal Genome Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Multi-Targeted Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multi-Targeted Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Personal Genome Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Personal Genome Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table PierianDx (Foundation Year, Company Profile and etc.)

    • Table PierianDx Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table PierianDx Personal Genome Testing Product and Service

    • Table Perkin Elmer, Inc (Foundation Year, Company Profile and etc.)

    • Table Perkin Elmer, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Perkin Elmer, Inc Personal Genome Testing Product and Service

    • Table F Hoffman-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffman-La Roche Ltd Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffman-La Roche Ltd Personal Genome Testing Product and Service

    • Table Oxford Nanopore Technologies (Foundation Year, Company Profile and etc.)

    • Table Oxford Nanopore Technologies Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Oxford Nanopore Technologies Personal Genome Testing Product and Service

    • Table DNASTAR, Inc (Foundation Year, Company Profile and etc.)

    • Table DNASTAR, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table DNASTAR, Inc Personal Genome Testing Product and Service

    • Table Genomatix GmbH (Foundation Year, Company Profile and etc.)

    • Table Genomatix GmbH Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genomatix GmbH Personal Genome Testing Product and Service

    • Table Bio-Rad Laboratories, Inc (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad Laboratories, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad Laboratories, Inc Personal Genome Testing Product and Service

    • Table BGI (Foundation Year, Company Profile and etc.)

    • Table BGI Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table BGI Personal Genome Testing Product and Service

    • Table Thermo Fisher Scientific, Inc (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific, Inc Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific, Inc Personal Genome Testing Product and Service

    • Table Illumina (Foundation Year, Company Profile and etc.)

    • Table Illumina Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Illumina Personal Genome Testing Product and Service

    • Table Eurofins GATC Biotech GmbH (Foundation Year, Company Profile and etc.)

    • Table Eurofins GATC Biotech GmbH Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eurofins GATC Biotech GmbH Personal Genome Testing Product and Service

    • Table QIAGEN (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Personal Genome Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Personal Genome Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.